Published: 25 February 2020
Author(s): Henri Bounameaux, Arnaud Perrier
Section: Commentary

Nobody could be more qualified than Jack Hirsh [1] to comment five decades of progress in the field of antithrombotic therapy, as he did in an authoritative review in the December issue of this Journal, along with his coworkers and colleagues John Eikelboom and Noel Chan [2].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.